Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Short-term Investments: 2009-2025

Historic Short-term Investments for Corcept Therapeutics (CORT) over the last 10 years, with Sep 2025 value amounting to $296.5 million.

  • Corcept Therapeutics' Short-term Investments rose 22.01% to $296.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $296.5 million, marking a year-over-year increase of 22.01%. This contributed to the annual value of $255.7 million for FY2024, which is 9.88% up from last year.
  • As of Q3 2025, Corcept Therapeutics' Short-term Investments stood at $296.5 million, which was up 23.83% from $239.5 million recorded in Q2 2025.
  • Corcept Therapeutics' 5-year Short-term Investments high stood at $365.3 million for Q4 2022, and its period low was $145.9 million during Q4 2021.
  • Over the past 3 years, Corcept Therapeutics' median Short-term Investments value was $243.0 million (recorded in 2024), while the average stood at $245.9 million.
  • Per our database at Business Quant, Corcept Therapeutics' Short-term Investments slumped by 59.97% in 2021 and then spiked by 150.38% in 2022.
  • Over the past 5 years, Corcept Therapeutics' Short-term Investments (Quarterly) stood at $145.9 million in 2021, then spiked by 150.38% to $365.3 million in 2022, then slumped by 36.31% to $232.7 million in 2023, then increased by 9.88% to $255.7 million in 2024, then grew by 22.01% to $296.5 million in 2025.
  • Its Short-term Investments was $296.5 million in Q3 2025, compared to $239.5 million in Q2 2025 and $232.9 million in Q1 2025.